Navigation Links
Cytopia and Other Progen Shareholders Maintain Call for Meeting
Date:2/8/2009

aries based in Melbourne, Australia and San Francisco, USA and specializes in developing new small molecule compounds with an improved therapeutic profile for the treatment of cancer.

The company's lead drug candidate is CYT997, a vascular disrupting agent (VDA) for the treatment of various cancers. It is currently being trialled in Phase II clinical studies. Cytopia is continuing to build on its range of JAK inhibitors and kinase expertise. CYT387, a novel, orally administered JAK2 inhibitor focused on the treatment of myeloproliferative disorders is expected to enter Phase I clinical studies in 2009.


'/>"/>
SOURCE Cytopia Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Presentation on Cytopias JAK2 Inhibitor Program in Myeloproliferative Disorders
2. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
3. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
4. Microtest Labs Offers Free Microbial Identification Testing, Free Shipping on Other Tests, to MD&M West Attendees
5. REXIN-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer: Analysis of a U.S. Phase I/II Clinical Trial (Proceedings of ASCO GI Symposium 2009)
6. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
7. GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years
8. BioLife Solutions Completes Safety Studies on HypoThermosol(R) and CryoStor(TM)
9. Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varians RapidArc(TM) Radiotherapy
10. Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
11. South Africas Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Junction, NJ (PRWEB) , ... July 27, 2015 , ... ... which identify and celebrate the top 100 most innovative technologies and services of the ... which was named in the Software/Services category. The winners will be announced at the ...
(Date:7/25/2015)... ... July 25, 2015 , ... Technology leader Anton Paar ... and adjusts the surface temperature of the measuring prism. This is required to ... traceability and documentation are key requirements. It is likely that no refractometer manufacturers ...
(Date:7/24/2015)... ... July 24, 2015 , ... VetStem Biopharma, proudly announces a new long term ... therapy training and clinical opportunities. , “We are very excited to be able to ... Diego area. Stem cell therapy is an established treatment for arthritic conditions in our ...
(Date:7/24/2015)... , July 24, 2015  Champions Oncology (OTC-BB: ... technology solutions and services to personalize the development and ... its financial and operational results for the fourth quarter ... Tuesday, July 28, 2015, before market open. ... the results that day at 9:00 a.m. EDT (6:00 ...
Breaking Biology Technology:Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2It’s T-Time for Refractometers: On-site Temperature Check Now Available 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 3Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2
... 14 GenVault Corporation today,announces that Mr. Mark ... of Business Development. Mr. Sutherland will be responsible ... licensing the company,s products and technologies as well ... Sutherland has more than 25 years experience in ...
... Oct. 14 Imaging,Diagnostic Systems, Inc., (OTC Bulletin ... imaging systems, announced today that its,distributor, Laszlo Meszaros ... Laser Mammography (CTLM(R)) system for Budapest, Hungary., ... system will be installed at the new MeDoc ...
... enable patient care services in Australia through ... retail pharmacies ... Convention --,Mirixa Corporation, the leader in pharmacy-based patient care services ... that they have signed a definitive technology licensing and business,consulting ...
Cached Biology Technology:Mark Sutherland Joins GenVault as Senior Vice President, Business Development 2Imaging Diagnostic Systems Sells Its CT Laser Mammography System to Budapest, Hungary 2Mirixa Announces Agreement With the Pharmacy Guild of Australia 2Mirixa Announces Agreement With the Pharmacy Guild of Australia 3
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/25/2015)... According to a new ... Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive & ... Others) & Geography - Global Forecast to 2014 ... is expected to reach $14,500.07 Million by 2020, ... Browse 76 market Tables and 109 Figures spread ...
(Date:6/25/2015)... N.J. , June 25, 2015  TAKE Solutions ... a patent by the United States Patent and Trademark ... Standardization". This process leverages TAKE Solutions, Clinical Accelerators to ... over 50% (when compared to standardization without the accelerators), ... At the heart of ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... the Inderscience publication, the International Journal of Environment ... from various fields explain how living organisms can ... pollutants, particulates, and trace elements. Borut Smodi, ... provides an editorial explaining how biomonitoring can be ...
... on the theory that dinosaurs, closest living relatives are ... a 68-million-year-old Tyrannosaurus rex protein from the dinosaur,s femur ... chickens, ostriches, and to a lesser extent, alligators. ... rex femur discovered in 2003 by paleontologist John Horner ...
... Mont. -- Natural barriers like waterfalls play an important ... National Park, so maintaining those barriers should be a ... four-year study in the park. Park workers might ... the water from rising behind those barriers, said graduate ...
Cached Biology News:Biomonitoring 2Genetic sequencing of protein from T. rex bone confirms dinosaurs' link to birds 2Montana State researchers study spread of lake trout in Glacier National Park 2